advertisement

WGA Rescources

Quiroga-Garza ME 16

Showing records 1 to 16 | Display all abstracts from Quiroga-Garza ME

104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Alvarez-Guzman C
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Ruiz-Lozano RE
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Alvarez-Guzman C; Alvarez-Guzman C
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Alamillo-Velazquez J
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Hartleben-Matkin C
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Ortiz-Morales G
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Ruiz-Lozano RE
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Garza-Garza LA
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Rodriguez-Garcia A; Quiroga-Garza ME
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Quiroga-Garza ME
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Quiroga-Garza ME
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Quiroga-Garza ME
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Valdez-Garcia JE
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Alvarez-Guzman C; Alvarez-Guzman C
International Ophthalmology 2023; 43: 677-695
104614 Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
Valdez-Garcia JE
Journal of Ophthalmic Inflammation and Infection 2022; 12: 22
104924 Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
Alvarez-Guzman C; Rodriguez-Garcia A
International Ophthalmology 2023; 43: 677-695

Issue 23-2

Change Issue


advertisement

Oculus